https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/reputation-index-2024/ 2025-10-15 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/general-public/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/general-public/overview/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/general-public/sharing-health-data/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/general-public/researching-and-developing-new-medicines/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/general-public/sector-image/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/general-public/access-to-new-medicines/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/general-public/relationship-with-the-nhs/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/members-of-parliament/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/members-of-parliament/domestic-contribution/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/members-of-parliament/overview/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/members-of-parliament/researching-and-developing-new-medicines/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/healthcare-professionals/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/healthcare-professionals/research-and-development/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/healthcare-professionals/relationship-with-the-nhs/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/healthcare-professionals/engagement-with-the-sector/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/healthcare-professionals/abpi-code-of-practice-and-disclosure-uk/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/healthcare-professionals/overview/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/segmentation/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/segmentation/overview/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/segmentation/key-driver-analysis/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/segmentation/supporters/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/segmentation/neutrals/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/segmentation/unfamiliar/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/segmentation/trusting-optimist/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/segmentation/detractors/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/covid-19-response/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/covid-19-response/members-of-parliament/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/covid-19-response/hcps/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/covid-19-response/general-public/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/methodology/ 2025-10-17 daily 0.5 https://2021.uk-pharma-reputation-index.stage.thisisembrace.net/cookies/ 2025-10-17 daily 0.5